TBIO logo

Telesis Bio (TBIO) Company Overview

Profile

Full Name:

Telesis Bio, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

June 18, 2021

Indexes:

Not included

Website:

http://telesisbio.com

Description:

Telesis Bio (TBIO) is a biotechnology company that focuses on developing innovative tools for DNA synthesis and genetic engineering. They provide advanced solutions for researchers and companies in the life sciences field, helping to accelerate discoveries in medicine, agriculture, and other areas.

Key Details

Price

$0.39

Market Cap

$29.48 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$27.51 M(+0.27% YoY)

Annual EPS

-$29.52(+0.61% YoY)

PE Ratio

-

Annual ROE

-161.57%

Annual Debt To Equity

1.16

Beta

0.88

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 9, 2024

Analyst ratings

Recent major analysts updates

Aug 11, 23 Keybanc
Sector Weight
Nov 9, 22 Keybanc
Overweight
Mar 28, 22 Keybanc
Overweight
Jul 13, 21 Keybanc
Overweight
Jul 13, 21 Jefferies
Buy
Jul 13, 21 Cowen & Co.
Outperform

Screeners with TBIO included

Stocks cheaper than 1 dollar
US stocks
Stocks below SMA 200
Most recommended stocks
Healthcare sector
All stocks
Small cap stocks
Medical Devices industry
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.39
TBIO price is $0.39

Price All-time High

$396.00
TBIO price is currently -99.90% below its historical high of $396.00

Price Analysts Target

-
TBIO price consensus analysts' forecast is unknown

Price Most Recent Change

0%
TBIO {parameterFullLabel} has remained unchanged on Feb 25, 2025

Price YTD Change

-2.5%
TBIO price is down -2.5% since January 1st

Price 3-Year Change

-99.78%
TBIO price is down -99.78% over the past 3 years

Market cap

Market Cap

$29.48 M
TBIO market capitalization is $29.48 million

Market Cap 3-Year Change

-99.78%
TBIO market capitalization is down -99.78% over the past 3 years

Market Cap All-time High

$29.84 B
TBIO market capitalization is currently -99.90% below its historical high of $29.84 billion

Market Cap Sector Rank

29.67%
TBIO market capitalization is higher than 29.67% of companies in Healthcare sector

Technical

Beta

0.88
TBIO beta is 0.88

200-day SMA

$2.35
TBIO price is currently -83.37% below its 200-day simple moving average

14-day RSI

50.51
TBIO 14-day relative strength index is 50.51

30-day Relative Volume

0.00
TBIO 30-day relative volume is 0.00

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$27.51 M
TBIO annual revenue is $27.51 million

Annual Revenue Analysts Estimate

$9.20 M
TBIO annual revenue is currently +199.01% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+0.27%
TBIO annual revenue is up +0.27% year-on-year

Annual Revenue Sector Rank

40.25%
TBIO annual revenue is higher than 40.25% of companies in Healthcare sector

Profit

Annual Gross Profit

$16.95 M
TBIO annual gross profit is $16.95 million

Annual Gross Margin

61.62%
TBIO annual gross profit margin is 61.62%

Annual Operating Profit

-$35.15 M
TBIO annual operating income is -$35.15 million

Annual Operating Margin

-127.78%
TBIO annual operating profit margin is -127.78%

Annual Net Income

-$47.72 M
TBIO annual net profit is -$47.72 million

Annual Net Margin

-
TBIO annual net profit margin value is unknown

EPS

Annual EPS

-$29.52
TBIO annual earnings per share is -$29.52

Annual EPS Analysts Estimate

-$24.95
TBIO annual earnings per share is currently +18.32% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+0.61%
TBIO annual earnings per share is up +0.61% year-on-year

Annual EPS Sector Rank

8.12%
TBIO annual earnings per share is higher than 8.12% of companies in Healthcare sector

ROA & ROE

Annual ROA

-67.78%
TBIO annual return on assets is -67.78%

Annual ROE

-161.57%
TBIO annual return on equity is -161.57%

EBIT & EBITDA

Annual EBIT

-$44.59 M
TBIO annual earnings before interest & taxes is -$44.59 million

Annual EBITDA

-$29.43 M
TBIO annual EBITDA is -$29.43 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TBIO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TBIO price to earnings ratio is unknown

PB Ratio

PB Ratio

-1.19
TBIO price to book ratio is -1.19

PB Ratio Sector Rank

9.18%
TBIO price to book ratio is higher than 9.18% of companies in Healthcare sector

PS Ratio

PS Ratio

1.68
TBIO price to sales ratio is 1.68

PS Ratio Sector Rank

36.47%
TBIO price to sales ratio is higher than 36.47% of companies in Healthcare sector

Enterprise value

Enterprise Value

$58.63 M
TBIO enterprise value is $58.63 million

Enterprise Value Sector Rank

42.32%
TBIO enterprise value is higher than 42.32% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.04
TBIO EV/EBITDA is -2.04

EV/EBITDA Sector Rank

36%
TBIO EV/EBITDA is higher than 36% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.71
TBIO annual current ratio is 3.71

Annual Quick Ratio

3.22
TBIO annual quick ratio is 3.22

Leverage

Annual Debt To Equity

1.16
TBIO annual debt to equity ratio is 1.16

Annual Interest Coverage Ratio

-14.36
TBIO annual interest coverage ratio is -14.36

Risk & Stability

Piotroski F-Score

3
TBIO piotroski f-score is 3

Altman Z-Score

-4.10
TBIO altman z-score is -4.10

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$70.41 M
TBIO annual total assets is $70.41 million

Annual Non Current Assets

$40.06 M
TBIO annual long term assets is $40.06 million

Annual Current Assets

$30.35 M
TBIO annual total current assets is $30.35 million

Annual Cash & Cash Equivalents

$1.57 M
TBIO annual cash & cash equivalents is $1.57 million

Equity

Annual Book Value

-$4.63 M
TBIO annual book value is -$4.63 million

Annual Working Capital

$22.17 M
TBIO annual working capital is $22.17 million

Liabilities

Annual Total Liabilities

$40.87 M
TBIO annual total liabilities is $40.87 million

Annual Total Long Term Liabilities

$32.69 M
TBIO annual total long term liabilities is $32.69 million

Annual Current Liabilities

$8.18 M
TBIO annual total current liabilities is $8.18 million

Annual Accounts Payable

$3.28 M
TBIO annual accounts payable is $3.28 million

Debt

Annual Total Debt

$34.38 M
TBIO annual total debt is $34.38 million

Annual Total Debt 1-Year Change

+60.45%
TBIO annual total debt is up +60.45% year-on-year

Annual Long Term Debt

$32.56 M
TBIO annual long term debt is $32.56 million

Annual Short Term Debt

-
TBIO annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$62.66 M
TBIO annual total expenses is $62.66 million

Annual Operating Expenses

$52.10 M
TBIO annual total operating expenses is $52.10 million

Annual Cost Of Goods Sold

$10.56 M
TBIO annual cost of goods sold is $10.56 million

Annual SGA

$34.60 M
TBIO annual SGA is $34.60 million

Annual D&A

$4.10 M
TBIO annual depreciation & amortization is $4.10 million

Annual Interest Expense

$3.10 M
TBIO annual interest expense is $3.10 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$34.67 M
TBIO annual cash flow from operations is -$34.67 million

Annual CFO 1-Year Change

+10.46%
TBIO annual cash flow from operations is up +10.46% year-on-year

Annual CFI

-$5.74 M
TBIO annual cash flow from investing activities is -$5.74 million

Annual CFI 1-Year Change

+68.1%
TBIO annual cash flow from investing activities is up +68.1% year-on-year

Annual CFF

$11.56 M
TBIO annual cash flow from financing activities is $11.56 million

Annual CFF 1-Year Change

+156.43%
TBIO annual cash flow from financing activities is up +156.43% year-on-year

Free CashFlow

Annual FCF

-$36.65 M
TBIO annual free cash flow is -$36.65 million

Annual FCF 1-Year Change

+15.14%
TBIO annual free cash flow is up +15.14% year-on-year

CAPEX

Annual CAPEX

$1.98 M
TBIO annual capital expenditures is $1.98 million

Annual CAPEX 1-Year Change

-55.68%
TBIO annual capital expenditures is down -55.68% year-on-year

Institutional Ownership

Similar stocks

COCH logo
Envoy Medical (COCH)
ONVO logo
Organovo Holdings (ONVO)
ONMD logo
OneMedNet (ONMD)
CMMB logo
Chemomab Therapeutics (CMMB)
PYPD logo
PolyPid (PYPD)
CalciMedica (CALC)
PLUR logo
Pluri (PLUR)
KALA logo
Kala Pharmaceuticals (KALA)
UBX logo
Unity Biotechnology (UBX)

FAQ

  • What is the ticker symbol for Telesis Bio?
  • Does Telesis Bio pay dividends?
  • What sector is Telesis Bio in?
  • What industry is Telesis Bio in?
  • What country is Telesis Bio based in?
  • When did Telesis Bio go public?
  • Is Telesis Bio in the S&P 500?
  • Is Telesis Bio in the NASDAQ 100?
  • Is Telesis Bio in the Dow Jones?
  • When does Telesis Bio report earnings?
  • Should I buy Telesis Bio stock now?

What is the ticker symbol for Telesis Bio?

The ticker symbol for Telesis Bio is NASDAQ:TBIO

Does Telesis Bio pay dividends?

No, Telesis Bio does not pay dividends

What sector is Telesis Bio in?

Telesis Bio is in the Healthcare sector

What industry is Telesis Bio in?

Telesis Bio is in the Medical Devices industry

What country is Telesis Bio based in?

Telesis Bio is headquartered in United States

When did Telesis Bio go public?

Telesis Bio's initial public offering (IPO) was on June 18, 2021

Is Telesis Bio in the S&P 500?

No, Telesis Bio is not included in the S&P 500 index

Is Telesis Bio in the NASDAQ 100?

No, Telesis Bio is not included in the NASDAQ 100 index

Is Telesis Bio in the Dow Jones?

No, Telesis Bio is not included in the Dow Jones index

When does Telesis Bio report earnings?

The date for Telesis Bio's next earnings report has not been announced yet

Should I buy Telesis Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions